About head and neck cancer
Various types of malignant tumors grown in and around head and neck are collectively known as head and neck cancers. Most head and neck cancers usually begin in the squamous cells that line the moist mucosal surfaces inside the mouth, throat, and nose. This is often identified as squamous cell carcinoma. The cancers start in the oral cavity, nasal cavity, larynx, salivary glands, pharynx, and paranasal sinuses. Also, other types of cancer may arise near the brain, thyroid, esophagus, and eye. Some of the diagnostic methods used to diagnose head and neck cancers are diagnostic imaging, endoscopy, biopsy, and dental diagnostics.
Technavio's analysts forecast the global head and neck cancer diagnostics market to grow at a CAGR of 12.86% over the period 2014-2019.
Covered in this report
In this report, Technavio covers the present scenario and growth prospects of the global head and neck cancer diagnostics market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of various equipment used for the following diagnostic methods:
• Diagnostic imaging
• Endoscopy
• Biopsy
• Dental diagnostics
Technavio's report, Global Head and Neck Cancer Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also presents the vendor landscape and a corresponding detailed analysis of the top-four vendors in the market. Also, it discusses the major drivers and challenges in the market, as well as the key trends.
Key regions
• Americas
• APAC
• EMEA
Key vendors
• GE Healthcare
• Philips Healthcare
• Siemens Healthcare
• Varian Medical Systems
Other prominent vendors
• Accuray
• Aribex
• ASAHI Roentgen
• BrainLab
• Bruker
• Carestream
• Elekta
• Esaote
• Fujifilm Holdings
• Hitachi Medical
• Hologic
• Identafi
• Karl Storz
• LED Medical Diagnostics
• Mediso
• MinXray
• Neurologica
• NeuSoft
• Shimadzu
• Toshiba
• Xoran
Market driver
• Increase in demand for diagnostic imaging
• For a full, detailed list, view our report
Market challenge
• High cost
• For a full, detailed list, view our report
Market trend
• Advances in technology
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Head and neck cancer: An overview
About the disease
Molecular diagnostics
PART 06: Reimbursement and coverage: An overview
Current scenario: Validating diagnostic tests
Reimbursement structure in the US
Reimbursement structure in EU
Prevailing issues of reimbursement policies
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by method
Diagnostic imaging
Endoscopy
Dental diagnostics
Biopsy
PART 09: Geographical segmentation
Head and neck cancer diagnostics market in Americas
Head and neck cancer diagnostics market in EMEA
Head and neck cancer diagnostics market in APAC
PART 10: Market drivers
Demand for diagnostic imaging
Focus on early disease diagnosis
Growth potential of emerging countries
PART 11: Impact of drivers
PART 12: Market challenges
High overall expenses
Reimbursement issues
Market saturation in developed countries
PART 13: Impact of drivers and challenges
PART 14: Market trends
Advances in technology
Use of multi-modality imaging systems
Biomarkers for cancer diagnosis
PART 15: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 16: Key vendor analysis
GE Healthcare
Philips Healthcare
Siemens Healthcare
Varian Medical Systems
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Risk factors for head and neck cancers
Exhibit 03: Reimbursement perspectives of healthcare entities
Exhibit 04: Global head and neck cancer diagnostics market 2014-2019 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Global head and neck cancer diagnostics market segmentation by method
Exhibit 07: Global head and neck cancer diagnostics market segmentation by method 2014
Exhibit 08: Global head and neck cancer diagnostics market segmentation by geography 2014
Exhibit 09: Head and neck cancer diagnostics market in Americas 2014-2019 ($ billions)
Exhibit 10: Head and neck cancer diagnostics market in EMEA 2014-2019 ($ billions)
Exhibit 11: Head and neck cancer diagnostics market in APAC 2014-2019 ($ billions)
Exhibit 12: Global head and neck cancer diagnostics market by geography 2014-2019 ($ billions)
Exhibit 13: Global head and neck cancer diagnostics market by geography 2014-2019
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: GE Healthcare: Key takeaways
Exhibit 17: Philips Healthcare: Key takeaways
Exhibit 18: Siemens Healthcare: Key takeaways
Exhibit 19: Varian Medical Systems: Key takeaways
Exhibit 20: Philips Healthcare: Business segmentation by revenue 2014
Exhibit 21: Geographical segmentation by revenue 2014
Exhibit 22: Siemens Healthcare: Business segmentation
Exhibit 23: Siemens Healthcare: Geographical segmentation by revenue 2014
Exhibit 24: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 25: Geographical segmentation by revenue 2014
